ROCKET LAB USA, INC. (RKLB) FY2025 Q1 Balance Sheet
As of 2025-03-31
Balance Sheet
As of 2025-03-31
Swipe to see the full flow
Chart details
ROCKET LAB USA, INC. (RKLB) FY2025 Q1 Balance Sheet
Balance sheet as of 2025-03-31. The chart shows assets, liabilities and equity at that date.
- Assets
- 1,254,973,000 US dollars
- Current assets
- 724,850,000 US dollars
- Non-current assets
- 530,123,000 US dollars
- Liabilities
- 823,679,000 US dollars
- Current liabilities
- 348,116,000 US dollars
- Non-current liabilities
- 475,563,000 US dollars
- Equity
- 431,294,000 US dollars
- Cash and cash equivalents
- 303,149,000 US dollars
- Inventories
- 125,588,000 US dollars
- Marketable securities, current
- 125,247,000 US dollars
- Prepaids and other current assets
- 70,510,000 US dollars
- Contract assets
- 60,943,000 US dollars
- Accounts receivable, net
- 39,413,000 US dollars
- Property, plant and equipment, net
- 213,990,000 US dollars
- Marketable securities, non-current
- 83,947,000 US dollars
- Goodwill
- 71,020,000 US dollars
- Intangible assets, net
- 56,181,000 US dollars
- Right-of-use assets - operating leases
- 52,137,000 US dollars
- Other non-current assets
- 29,709,000 US dollars
- Right-of-use assets - finance leases
- 14,272,000 US dollars
- Restricted cash
- 5,102,000 US dollars
- Deferred income tax assets, net
- 3,765,000 US dollars
- Contract liabilities
- 206,867,000 US dollars
- Trade payables
- 70,203,000 US dollars
- Employee benefits payable
- 21,959,000 US dollars
- Current installments of long-term borrowings
- 20,490,000 US dollars
- Other current liabilities
- 16,456,000 US dollars
- Accrued expenses
- 12,141,000 US dollars
- Convertible senior notes, net
- 345,926,000 US dollars
- Long-term borrowings, net, excluding current installments
- 57,728,000 US dollars
- Non-current operating lease liabilities
- 50,643,000 US dollars
- Non-current finance lease liabilities
- 14,897,000 US dollars
- Other non-current liabilities
- 5,342,000 US dollars
- Deferred tax liabilities
- 1,027,000 US dollars
- Additional paid-in capital
- 1,307,930,000 US dollars
- Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued shares: 511,492,231 and 504,453,785 at March 31, 2025 and December 31, 2024, respectively; outstanding shares: 460,540,981 and 504,453,785 at March 31, 2025 and December 31, 2024, respectively
- 46,000 US dollars
- Preferred stock, $0.0001 par value; authorized shares: 100,000,000; issued and outstanding shares: 50,951,250 and 0 at March 31, 2025 and December 31, 2024, respectively
- 5,000 US dollars
- Treasury stock, at cost; shares: 50,951,250 and 0 at March 31, 2025 and December 31, 2024, respectively
- 0 US dollars
- Accumulated deficit
- negative 874,317,000 US dollars
- Accumulated other comprehensive loss
- negative 2,370,000 US dollars
- Gross equity (calculated)
- 1,307,981,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
